PPD’ buy expands presence in booming CEE

By Nick Taylor

- Last updated on GMT

Related tags Eastern europe Romania Europe

PPD has reached an agreement to buy AbCRO, which it hopes will strengthen its position in the thriving Central and Eastern European (CEE) clinical trials scene.

Through the acquisition PPD will gain a presence in Romania, Bulgaria, Serbia and Croatia and the infrastructure and expertise that AbCRO has in these markets.

In addition the purchase will enhance PPD’s operations in Poland, Ukraine and Russia, which are increasingly being recognised as key markets for conducting clinical trials.

Fred Eshelman, CEO of PPD, said: "This acquisition will strengthen our foothold in Central and Eastern Europe and enhance our ability to conduct global trials for our clients​.

We see many synergies with AbCRO and anticipate a relatively seamless integration, with many of the AbCRO employees already well-versed on basic PPD procedures and systems​."

PPD initially moved into clinical trials in CEE through the acquisition of InnoPharm and since then has enhanced its presence. The acquisition of AbCRO will further cement its position in the region but the level of interest in CEE is making it an increasingly competitive market place.

For instance, Covance has recently expanded its presence in the market through the opening of offices in Ukraine, Slovakia and Israel. The majority of these markets offer a large pool of treatment naïve Caucasian patients which makes recruiting for trials far quicker.

In addition a recent RNCOS stated that: “with a sizeable population still unable to afford costly medications, the number of potential patients participating in clinical trials is expected to be large​.”

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more